Use of an Early Disease-Modifying Drug Adherence Measure to Predict Future Adherence in Patients with Multiple Sclerosis

BACKGROUND: Patients with multiple sclerosis (MS) who are adherent to their treatment regimens are less likely to experience relapses and the cost associated with relapse. Pharmacists whose practice involves these specialty pharmaceuticals used to treat MS are striving for ways to improve outcomes b...

Descripción completa

Detalles Bibliográficos
Autores principales: Kozma, Chris M., Phillips, Amy L., Meletiche, Dennis M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437671/
https://www.ncbi.nlm.nih.gov/pubmed/25062073
http://dx.doi.org/10.18553/jmcp.2014.20.8.800

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437671/
https://www.ncbi.nlm.nih.gov/pubmed/25062073
http://dx.doi.org/10.18553/jmcp.2014.20.8.800

Ejemplares similares